The Increasing Penetration of Specialized Orphan Drugs: Core Drivers of South Korea Dravet Syndrome Market growth
  The compelling South Korea Dravet Syndrome Market growth is fundamentally driven by the success of targeted therapeutic developments and increased government support for rare diseases. Dravet Syndrome, defined by its resistance to conventional anti-epileptic drugs, saw a stagnant treatment landscape until the approval and successful introduction of specialized orphan drugs such as...
0 Comentários 0 Compartilhamentos 415 Visualizações 0 Anterior